Skip to main content
Fig. 2 | Trials

Fig. 2

From: Comparing the efficacy of a web-assisted calprotectin-based treatment algorithm (IBD-live) with usual practices in teenagers with inflammatory bowel disease: study protocol for a randomized controlled trial

Fig. 2

Graphical representation of flarometer test frequency and treatment advice. In the high-risk stratum, clinical relapse is suspected and the local IBD-team is advised to intensify treatment and remeasure in one month. In the low-risk stratum, maintenance therapy remains unchanged and an alert to use the flarometer will be sent in three months. In the intermediate range, drug adherence is optimised and the flarometer will be used again in a month. After two consecutive intermediate results the local IBD-team is advised to intensify treatment. This scenario is shown at eight months. IBD Inflammatory bowel disease

Back to article page

Trials

ISSN: 1745-6215